Solicitation - Attachment 1 - Statement of Work - NCI SBIR Innovative Concept Award.pdf
PDF 1 MB Posted
- Solicitation number
- 75N91020R00043
About this file
This statement of work outlines technical objectives and milestones for an innovative concept award from the National Cancer Institute. Key details include: developing a technology or product focused on pediatric or rare cancers in one sentence; describing clinical need and impact in 1500 characters; listing quantitative, measurable objectives and milestones over a 12-month period to develop proof of concept; and participating in the I-Corps training program to enhance commercialization skills. The solicitation seeks proposals from eligible small businesses to demonstrate technical feasibility of bold ideas with sound scientific basis that could create new cancer therapies, diagnostics or preventatives.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Solicitation 75N91020R00043 - NCI SBIR Concept Award -.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Statement of Work Date Contract No.
NCI SBIR Innovative Concept Award
Statement of Work
Title of the Project:
Principal Investigator(s):
Offeror Small Business Name:
Subcontractors and Collaborators:
I. Technology and Product (Scope) (Please provide one sentence description of your technology and final product; up to 250 characters with spaces)
II. Significance and Potential Impact (Please identify the clinical need that you are addressing and significance of your technology and the impact of your technology for rare or pediatric cancer populations. This section will be displayed on the public databases such as NIH RePORTER; up to 1500 characters with spaces)
III. Technical Objectives and Milestones The contractor shall independently perform all work and furnish all labor, materials, supplies, equipment, and services (except as otherwise specified in the contract) to perform the following services:
(List all tasks in a logical sequence. Tasks should contain enough detail to establish parameters for the project and keep the effort focused on meeting the objectives. Provide clear, quantitative, measurable, testable milestones or success criteria to accompany each of the technical objectives. Correlate objectives and milestones with the TIMELINE section, below. Do not include proprietary information. Technical objectives, but not milestones, will be displayed on public databases such as NIH RePORTER; up to 2000 characters with spaces)
IV. Timeline (Please put (×) next to the month when you anticipate working on this objective. Please fill in the information only for your number of objectives and milestones.)
Objective/Sub- Objective Milestones Timeline in Months
1 2 3 4 5 6 7 8 9 10 11 12
V. I-Corps™ at NIH
Offeror agrees to participate in the I-Corps Program at NIH The Contractor will complete the I-Corps™ at NIH program, including the requirements below.
A. The Contractor’s 3-member I-Corps™ team shall participate at all lectures and sessions for a 3-day Opening workshop and a 2-day Closing workshop for the I-Corps™ at NIH program.
B. The Contractor’s 3-member I-Corps™ team shall prepare and submit Customer Discovery Interviews and Team Presentations in accordance with the I-Corps™ at NIH program and in accordance with the REPORTING REQUIREMENTS and DELIVERIES articles of this contract.
C. The Contractor’s 3-member I-Corps™ team shall participate in weekly faculty meetings during the 8-week I-Corps™ program.
D. The Contractor’s 3-member I-Corps™ team shall participate in 6 I-Corps™ Webex sessions.
E. The Contractor’s 3-member I-Corps™ team shall prepare an I-Corps™ at NIH Lessons Learned Video and incorporate an I-Corps™ section into the Commercialization Plan within the SBIR Phase I Final Report, in accordance with the REPORTING REQUIREMENTS and DELIVERIES articles of this contract.
Any changes to the Contractor’s 3-member I-Corps™ at NIH team must be approved in advance by the Government for the requirements and deliverables associated with I-Corps to be considered satisfactory and I-Corps Payment Schedule items to be authorized.
Submission of Final Report ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐
VI. Vertebrate Animals Section (If the project will involve Vertebrate Animals, fill out this section in accordance with instructions set forth in Section 8.8 of the solicitation. If the project will not involve Vertebrate Animals, leave as “N/A”.)
Blank Page
| Title of the Project: |
| Principal Investigators: |
| Offeror Small Business Name: |
| Subcontractors and Collaborators: |
| Kick off Call: Kick-off Call |
| Date: |
| Technical Objectives and Milestones: |
| Technology and Product: |
| Significance and Potential Impact: |
| Contract No: NIH Office Use Only |
| Objective 1: Objective 1 |
| Objective 2: |
| Objective 3: |
| Objective 4: |
| Objective 6: |
| Objective 5: |
| Objective 7: |
| Objective 8: |
| Objective 9: |
| Objective 10: |
| Objective 11: |
| Line 1 Month 1: Off |
| Line 1 Month 2: Off |
| Line 1 Month 3: Off |
| Line 1 Month 4: Off |
| Line 1 Month 5: Off |
| Line 1 Month 6: Off |
| Line 1 Month 7: Off |
| Line 1 Month 8: Off |
| Line 1 Month 9: Off |
| Line 1 Month 10: Off |
| Line 1 Month 11: Off |
| Line 1 Month 12: Off |
| Line 2 Month 1: Off |
| Line 2 Month 2: Off |
| Line 2 Month 3: Off |
| Line 2 Month 4: Off |
| Line 2 Month 5: Off |
| Line 2 Month 6: Off |
| Line 2 Month 7: Off |
| Line 2 Month 8: Off |
| Line 2 Month 9: Off |
| Line 2 Month 10: Off |
| Line 2 Month 11: Off |
| Line 2 Month 12: Off |
| Line 3 Month 1: Off |
| Line 3 Month 2: Off |
| Line 3 Month 3: Off |
| Line 3 Month 4: Off |
| Line 3 Month 5: Off |
| Line 3 Month 6: Off |
| Line 3 Month 7: Off |
| Line 3 Month 8: Off |
| Line 3 Month 9: Off |
| Line 3 Month 10: Off |
| Line 3 Month 11: Off |
| Line 3 Month 12: Off |
| Line 4 Month 1: Off |
| Line 4 Month 2: Off |
| Line 4 Month 3: Off |
| Line 4 Month 4: Off |
| Line 4 Month 5: Off |
| Line 4 Month 6: Off |
| Line 4 Month 7: Off |
| Line 4 Month 8: Off |
| Line 4 Month 9: Off |
| Line 4 Month 10: Off |
| Line 4 Month 11: Off |
| Line 4 Month 12: Off |
| I-Corps at NIH Option: Off |
| Line 5 Month 1: Off |
| Line 5 Month 2: Off |
| Line 5 Month 3: Off |
| Line 5 Month 4: Off |
| Line 5 Month 5: Off |
| Line 5 Month 6: Off |
| Line 5 Month 7: Off |
| Line 5 Month 8: Off |
| Line 5 Month 9: Off |
| Line 5 Month 10: Off |
| Line 5 Month 11: Off |
| Line 5 Month 12: Off |
| Line 6 Month 1: Off |
| Line 6 Month 2: Off |
| Line 6 Month 3: Off |
| Line 6 Month 4: Off |
| Line 6 Month 5: Off |
| Line 6 Month 6: Off |
| Line 6 Month 7: Off |
| Line 6 Month 8: Off |
| Line 6 Month 9: Off |
| Line 6 Month 10: Off |
| Line 6 Month 11: Off |
| Line 6 Month 12: Off |
| Line 7 Month 1: Off |
| Line 7 Month 2: Off |
| Line 7 Month 3: Off |
| Line 7 Month 4: Off |
| Line 7 Month 5: Off |
| Line 7 Month 6: Off |
| Line 7 Month 7: Off |
| Line 7 Month 8: Off |
| Line 7 Month 9: Off |
| Line 7 Month 10: Off |
| Line 7 Month 11: Off |
| Line 7 Month 12: Off |
| Line 8 Month 1: Off |
| Line 8 Month 2: Off |
| Line 8 Month 3: Off |
| Line 8 Month 4: Off |
| Line 8 Month 5: Off |
| Line 8 Month 6: Off |
| Line 8 Month 7: Off |
| Line 8 Month 8: Off |
| Line 8 Month 9: Off |
| Line 8 Month 10: Off |
| Line 8 Month 11: Off |
| Line 8 Month 12: Off |
| Line 9 Month 1: Off |
| Line 9 Month 2: Off |
| Line 9 Month 3: Off |
| Line 9 Month 4: Off |
| Line 9 Month 5: Off |
| Line 9 Month 6: Off |
| Line 9 Month 7: Off |
| Line 9 Month 8: Off |
| Line 9 Month 9: Off |
| Line 9 Month 10: Off |
| Line 9 Month 11: Off |
| Line 9 Month 12: Off |
| Line 10 Month 1: Off |
| Line 10 Month 2: Off |
| Line 10 Month 3: Off |
| Line 10 Month 4: Off |
| Line 10 Month 5: Off |
| Line 10 Month 6: Off |
| Line 10 Month 7: Off |
| Line 10 Month 8: Off |
| Line 10 Month 9: Off |
| Line 10 Month 10: Off |
| Line 10 Month 11: Off |
| Line 10 Month 12: Off |
| Line 11 Month 1: Off |
| Line 11 Month 2: Off |
| Line 11 Month 3: Off |
| Line 11 Month 4: Off |
| Line 11 Month 5: Off |
| Line 11 Month 6: Off |
| Line 11 Month 7: Off |
| Line 11 Month 8: Off |
| Line 11 Month 9: Off |
| Line 11 Month 10: Off |
| Line 11 Month 11: Off |
| Line 11 Month 12: Off |
| Line 12 Month 1: Off |
| Line 12 Month 2: Off |
| Line 12 Month 3: Off |
| Line 12 Month 4: Off |
| Line 12 Month 5: Off |
| Line 12 Month 6: Off |
| Line 12 Month 7: Off |
| Line 12 Month 8: Off |
| Line 12 Month 9: Off |
| Line 12 Month 10: Off |
| Line 12 Month 11: Off |
| Line 12 Month 12: Off |
| Submission of Final Report Month 1: Off |
| Submission of Final Report Month 2: Off |
| Submission of Final Report Month 3: Off |
| Submission of Final Report Month 4: Off |
| Submission of Final Report Month 5: Off |
| Submission of Final Report Month 6: Off |
| Submission of Final Report Month 7: Off |
| Submission of Final Report Month 8: Off |
| Submission of Final Report Month 9: Off |
| Submission of Final Report Month 10: Off |
| Submission of Final Report Month 11: Off |
| Submission of Final Report Month 12: Off |
| Milestone: |
| Milestone 1: Milestone 1 |
| Milestone 2: |
| Milestone 3: |
| Milestone 4: |
| Milestone 5: |
| Milestone 6: |
| Milestone 7: |
| Milestone 8: |
| Milestone 9: |
| Milestone 10: |
| Milestone 11: |
| Vertebrate Animal Section: |
File details come from the government source that posted it. Updated .